Lanreotide Acetate and Posaconazole Delayed-Release Tablets
Determining the interaction of Lanreotide Acetate and Posaconazole Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Acetate-Posaconazole Injection
- Lanreotide Acetate-Posaconazole Intravenous
- Lanreotide Acetate-Posaconazole Oral Suspension
- Lanreotide Acetate-Posaconazole oral/injection
- Lanreotide Acetate-Posaconazole Tablets
- Lanreotide Acetate-PosiFlush flush
- Posaconazole Delayed-Release Tablets-Lanreotide Subcutaneous
- Posaconazole Delayed-Release Tablets-Lansoprazole
- Posaconazole Delayed-Release Tablets-Lansoprazole Delayed-Release Capsules
- Posaconazole Delayed-Release Tablets-Lansoprazole Orally Disintegrating Tablets
- Posaconazole Delayed-Release Tablets-Lansoprazole, Amoxicillin, and Clarithromycin
- Posaconazole Delayed-Release Tablets-Lanthanum